SEC Form 4 · accession 0001104659-18-070875
BioXcel Therapeutics, Inc. · BTAI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Yocca
Officer — Chief Scientific Officer
Period of report
Nov 30, 2018
Accepted (ET)
Nov 30, 2018 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720893
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2018 | P | 450 | $5.199 | A | 950 | D |
Table II — derivative securities
No Table II lines on this filing.